Research Summary
Axsome Therapeutics almost doubles on positive outcome from Alzheimer’s disease trial
Clinical stage biopharmaceutical company Axsome Therapeutics (AXSM) announces positive outcome for ADVANCE-1 trial associated with the treatment of Alzheimer's disease. Shares of…
Bristol-Myers Squibb swallows Celgene for $74-bln; Celgene stock surges
Bristol-Myers Squibb (NYSE: BMY) acquired its peer Celgene (NASDAQ: CELG) in a $74-billion cash-and-stock deal. Under the agreement terms, Celgene…
Nvidia shares jump after Citron Research buys stock
Short-seller Citron Research on Tuesday tweeted that it bought shares of Nvidia Corp (NVDA). Shares of the graphics chipset maker…
Nine years after launch, Beyond Meat goes public
Last Friday, Beyond Meat filed its prospectus to go public on Nasdaq under the symbol “BYND”. The veggie company, which…